Monitor post-liver-transplant therapy with hepatitis B immunoglobulin in HBV-positive patients and ascertain response to HBV vaccines.
Quantitative Chemiluminescent Immunoassay
Within 24 hours
Serum separator tube. Also acceptable: Lavender (EDTA) or pink (K2EDTA).
Separate serum or plasma from cells ASAP or within 2 hours of collection. Transfer 1 mL serum to an ARUP Standard Transport Tube. (Min: 0.5 mL)
Heparinized plasma. Specimens containing particulate material. Heat-inactivated , severely hemolyzed, or lipemic specimens.
After separation from cells: Ambient: Unacceptable; Refrigerated: 1 week; Frozen: Indefinitely (avoid repeated freeze/thaw cycles)
|Less than 10.00 IU/L||Negative|
|Greater than or equal to 10.00 IU/L||Positive|
This assay should not be used for blood donor screening, associated re-entry protocols, or for screening Human Cell, Tissues and Cellular and Tissue-Based Products (HCT/P).
No compliance statements are in use for this test.
Results greater than 1,000.00 IU/L are reported as greater than 1,000.00 IU/L
|Component Test Code*||Component Chart Name||LOINC|
|0020090||Hepatitis B Surface Antibody||5193-8|
- Anti-HBs Titer, S
- Anti-Hepatitis Bs
- Antibody Titer to Hep B Surface Ag
- Antibody to Hepatitis B Surface Antigen
- HBV Hep B Surface Ab
- Hepatitis B Immunity
- Hepatitis B Surface Antibody, Quantitative
- Hepatitis Bs